APO RESEARCH · REPORT
Coronary Artery Bypass Grafts (CABG)
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Product & engineering
Understand the product.
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Selected research
Industry Research
Coronary Artery Bypass Grafts (CABG) Industry Research Report 2026
Market perspective
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
Read the full market overview
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Scope
This report quantifies the global Coronary Artery Bypass Grafts (CABG) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Coronary Artery Bypass Grafts (CABG).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coronary Artery Bypass Grafts (CABG) Market by Company
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Coronary Artery Bypass Grafts (CABG) Segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other
Coronary Artery Bypass Grafts (CABG) Segment by Application
Traditional CABG
Nontraditional CABG
Coronary Artery Bypass Grafts (CABG) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Artery Bypass Grafts (CABG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coronary Artery Bypass Grafts (CABG) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Artery Bypass Grafts (CABG).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Coronary Artery Bypass Grafts (CABG) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Saphenous Vein Grafts
- Internal Thoracic Artery Grafts
- Other
Applications
- Traditional CABG
- Nontraditional CABG
Companies covered
- Medtronic
- Getinge Group
- LivaNova
- Terumo
- Boston Scientific
- Stryker
- Edwards Lifesciences
- Genesee Biomedical
- Karl Storz GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Coronary Artery Bypass Grafts (CABG) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Saphenous Vein Grafts
- 2.2.3 Internal Thoracic Artery Grafts
- 2.2.4 Other
- 2.3 Coronary Artery Bypass Grafts (CABG) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Traditional CABG
- 2.3.3 Nontraditional CABG
- 2.4 Assumptions and Limitations
3 Coronary Artery Bypass Grafts (CABG) Breakdown Data by Type
- 3.1 Global Coronary Artery Bypass Grafts (CABG) Historic Market Size by Type (2021-2026)
- 3.2 Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Type (2027-2032)
4 Coronary Artery Bypass Grafts (CABG) Breakdown Data by Application
- 4.1 Global Coronary Artery Bypass Grafts (CABG) Historic Market Size by Application (2021-2026)
- 4.2 Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Coronary Artery Bypass Grafts (CABG) Market Perspective (2021-2032)
- 5.2 Global Coronary Artery Bypass Grafts (CABG) Growth Trends by Region
- 5.2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Coronary Artery Bypass Grafts (CABG) Historic Market Size by Region (2021-2026)
- 5.2.3 Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Region (2027-2032)
- 5.3 Coronary Artery Bypass Grafts (CABG) Market Dynamics
- 5.3.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
- 5.3.2 Coronary Artery Bypass Grafts (CABG) Market Drivers
- 5.3.3 Coronary Artery Bypass Grafts (CABG) Market Challenges
- 5.3.4 Coronary Artery Bypass Grafts (CABG) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Coronary Artery Bypass Grafts (CABG) Players by Revenue
- 6.1.1 Global Top Coronary Artery Bypass Grafts (CABG) Players by Revenue (2021-2026)
- 6.1.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Players (2021-2026)
- 6.2 Global Coronary Artery Bypass Grafts (CABG) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Coronary Artery Bypass Grafts (CABG) Head Office and Area Served
- 6.4 Global Coronary Artery Bypass Grafts (CABG) Players, Product Type & Application
- 6.5 Global Coronary Artery Bypass Grafts (CABG) Manufacturers Established Date
- 6.6 Global Coronary Artery Bypass Grafts (CABG) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
- 7.2 North America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2021-2026)
- 7.4 North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
- 8.2 Europe Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2021-2026)
- 8.4 Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
- 9.2 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
- 10.2 South America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2021-2026)
- 10.4 South America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
- 11.2 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Getinge Group
- 12.2.1 Getinge Group Company Information
- 12.2.2 Getinge Group Business Overview
- 12.2.3 Getinge Group Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.2.5 Getinge Group Recent Developments
- 12.3 LivaNova
- 12.3.1 LivaNova Company Information
- 12.3.2 LivaNova Business Overview
- 12.3.3 LivaNova Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.3.5 LivaNova Recent Developments
- 12.4 Terumo
- 12.4.1 Terumo Company Information
- 12.4.2 Terumo Business Overview
- 12.4.3 Terumo Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.4.5 Terumo Recent Developments
- 12.5 Boston Scientific
- 12.5.1 Boston Scientific Company Information
- 12.5.2 Boston Scientific Business Overview
- 12.5.3 Boston Scientific Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.5.5 Boston Scientific Recent Developments
- 12.6 Stryker
- 12.6.1 Stryker Company Information
- 12.6.2 Stryker Business Overview
- 12.6.3 Stryker Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.6.5 Stryker Recent Developments
- 12.7 Edwards Lifesciences
- 12.7.1 Edwards Lifesciences Company Information
- 12.7.2 Edwards Lifesciences Business Overview
- 12.7.3 Edwards Lifesciences Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.7.5 Edwards Lifesciences Recent Developments
- 12.8 Genesee Biomedical
- 12.8.1 Genesee Biomedical Company Information
- 12.8.2 Genesee Biomedical Business Overview
- 12.8.3 Genesee Biomedical Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.8.5 Genesee Biomedical Recent Developments
- 12.9 Karl Storz GmbH
- 12.9.1 Karl Storz GmbH Company Information
- 12.9.2 Karl Storz GmbH Business Overview
- 12.9.3 Karl Storz GmbH Revenue in Coronary Artery Bypass Grafts (CABG) Business (2021-2026)
- 12.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product Portfolio
- 12.9.5 Karl Storz GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst